Epigallocatechin gallate (EGCG) binds to low-density lipoproteins (LDL) and protects them from oxidation and glycation under high-glucose conditions mimicking diabetes

Food Chemistry

Volumn 121, Issue 3, 2010, Pages 639-644

  Wu, Chi Hao ^a   Yeh, Chi Tai ^b   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Binding; EGCG; Glucose; Glycation; LDL; Oxidation

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; APOLIPOPROTEIN B; CUPRIC ION; EPIGALLOCATECHIN GALLATE; LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIGLYCATION ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG PROTEIN BINDING; FRAGMENTATION REACTION; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; INCUBATION TIME; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PROTEIN ISOLATION; SOLID PHASE EXTRACTION; ULTRACENTRIFUGATION;

EID: 77649178820     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2010.02.008     Document Type: Article

References (32)

1. Basu A., and Lucas E.A. Mechanisms and effects of green tea on cardiovascular health. Nutrition Reviews 65 1 (2007) 361-375
2. Belinky P.A., Aviram M., Fuhrman B., Rosenblat M., and Vaya J. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis 137 1 (1998) 49-61
3. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Current Opinion in Clinical Nutrition and Metabolic Care 5 5 (2002) 561-568
4. (2+)-oxidizability: Possible explanation by phenolic location. European Journal of Clinical Nutrition 51 10 (1997) 682-690
5. Esterbauer H., Striegl G., Puhl H., and Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communications 6 1 (1989) 67-75
6. Graham H.N. Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine 21 3 (1992) 334-350
7. Hosoda K., Wang M.F., Liao M.L., Chuang C.K., Iha M., Clevidence B., et al. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 26 6 (2003) 1714-1718
8. Iso H., Date C., Wakai K., Fukui M., and Tamakoshi A. The relationship between green tea and total caffeine intake and risk for self-reported type-2 diabetes among Japanese adults. Annals of Internal Medicine 144 8 (2006) 554-562
9. Jenkins A.J., Best J.D., Klein R.L., and Lyons T.J. Lipoproteins, glycoxidation and diabetic angiopathy. Diabetes/Metabolism Research and Reviews 20 5 (2004) 349-368
10. Lamuela-Raventós R.M., Covas M.I., Fitó M., Marrugat J., and de La Torre-Boronat M.C. Detection of dietary antioxidant phenolic compounds in human LDL. Clinical Chemistry 45 10 (1999) 1870-1872
11. Lang J.K., Gohil K., and Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Analytical Biochemistry 157 1 (1986) 106-116
12. Leenen R., Roodenburg A.J., Vissers M.N., Schuurbiers J.A., van Putte K.P., Wiseman S.A., et al. Supplementation of plasma with olive oil phenols and extracts: Influence on LDL oxidation. Journal of Agricultural and Food Chemistry 50 5 (2002) 1290-1297
13. Li D., Devaraj S., Fuller C., Bucala R., and Jialal I. Effect of alpha-tocopherol on LDL oxidation and glycation: In vitro and in vivo studies. Journal of Lipid Research 37 9 (1996) 1778-1786
14. Lourenço C.F., Gago B., Barbosa R.M., de Freitas V., and Laranjinha J. LDL isolated from plasma-loaded red wine procyanidins resist lipid oxidation and tocopherol depletion. Journal of Agricultural and Food Chemistry 56 10 (2008) 3798-3804
15. Milde J., Elstner E.F., and Grassmann J. Synergistic effects of phenolics and carotenoids on human low-density lipoprotein oxidation. Molecular Nutrition and Food Research 51 8 (2007) 956-961
16. Miura Y., Chiba T., Miura S., Tomita I., Umegaki K., Ikeda M., et al. Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: An ex vivo study in humans. The Journal of Nutritional Biochemistry 11 4 (2000) 216-222
17. Montonen J., Knekt P., Jarvinen R., and Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27 7 (2004) 362-366
18. Nakagawa K., Okuda S., and Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigaallocatechin, into human plasma. Bioscience, Biotechnology and Biochemistry 61 12 (1997) 1981-1985
19. Sakata N., Uesugi N., Takebayashi S., Nagai R., Jono T., Horiuchi S., et al. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis. Cardiovascular Research 49 2 (2001) 466-475
20. Sang S., Shao X., Bai N., Lo C.Y., Yang C.S., and Ho C.T. Tea polyphenol (-)-epigallocatechin-3-gallate: A new trapping agent of reactive dicarbonyl species. Chemical Research in Toxicology 20 12 (2007) 1862-1870
21. Sazuka M., Itoi T., Suzuki Y., Odani S., Koide T., and Isemura M. Evidence for the interaction between (-)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein. Bioscience, Biotechnology and Biochemistry 60 8 (1996) 1317-1319
22. Sobal G., Menzel J., and Sinzinger H. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins, Leukotrienes and Essential Fatty Acids 63 4 (2000) 177-186
23. Sobal G., Menzel E.J., and Sinzinger H. Troglitazone inhibits long-term glycation and oxidation of low-density lipoprotein. Journal of Cardiovascular Pharmacology 46 5 (2005) 672-680
24. Sung H., Min W.K., Lee W., Chun S., Park H., Lee Y.W., et al. The effects of green tea ingestion over 4 weeks on atherosclerotic markers. Annals of Clinical Biochemistry 42 4 (2005) 292-297
25. Thielecke F., and Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome - A review. Phytochemistry 70 1 (2009) 11-24
26. Ullmann U., Haller J., and Decourt J.P. A single ascending dose study of epigallocatechin gallate in healthy volunteers. The Journal of International Medical Research 31 2 (2003) 88-101
27. Wolff S.P., and Dean R.T. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. The Biochemical Journal 245 1 (1987) 243-250
28. Wu C.H., Lin J.A., Hsieh W.C., and Yen G.C. Low-density-lipoprotein (LDL)-bound flavonoids increase the resistance of LDL to oxidation and glycation under pathophysiological concentrations of glucose in vitro. Journal of Agricultural and Food Chemistry 57 11 (2009) 5058-5064
29. Wu C.H., Wu C.F., Huang H.W., Jao R.C., and Yen G.C. Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells. Molecular Nutrition and Food Research 53 8 (2009) 984-995
30. Wu C.H., and Yen G.C. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. Journal of Agricultural and Food Chemistry 53 8 (2005) 3167-3173
31. Yamabe N., Yokozawa T., Oya T., and Kim M. Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. The Journal of Pharmacology and Experimental Therapeutics 319 1 (2006) 228-236
32. Yang C.S., Chen L., Lee M.J., Balentine D., Kuo M.C., and Schantz S.P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiology Biomarkers and Prevention 7 4 (1998) 351-354